Catheter Precision, Inc. — financial figures as filed

CIK 1716621 · 10 fiscal years on record

Every figure below is taken from a filed report through an explicit tag map and carries the tag and accession number it came from. A metric the company did not disclose is shown as , never as zero.

Aggregates

computed from the figures below
Metrics filled
12 / 12
canonical metrics mapped from the filings
Mapping completeness
100.0%
all metrics present
Fiscal years on record
10
Quarters on record
26
Revenue change, latest year
+95.0%
against the preceding fiscal year
Revenue growth run
1 yr
consecutive years higher than the previous
Years with income above zero
0
9 years below zero on record
Revenue rank in peer group
580 / 629
by latest annual revenue
Disclosure lag
90 d
period end to filing date
Latest period end
2025-12-31
filed 2026-03-31
Periods that do not reconcile
0
four quarters against the reported year

Explainable annual analytics

latest annual period where both published inputs exist
Ratios are arithmetic over reported SEC facts, not ratings, forecasts or investment advice.
MetricValueFiscal yearInputsSource tags
Gross margin92.3%FY2025Gross profit: $756KRevenue: $819KGrossProfit / RevenueFromContractWithCustomerExcludingAssessedTax
Operating margin-2,581.6%FY2025Operating income: -$21.1MRevenue: $819KOperatingIncomeLoss / RevenueFromContractWithCustomerExcludingAssessedTax
Net margin-2,098.0%FY2025Net income: -$17.2MRevenue: $819KNetIncomeLoss / RevenueFromContractWithCustomerExcludingAssessedTax
Operating cash-flow margin-1,012.9%FY2025Operating cash flow: -$8.3MRevenue: $819KNetCashProvidedByUsedInOperatingActivities / RevenueFromContractWithCustomerExcludingAssessedTax
Return on assets-108.3%FY2025Net income: -$17.2MTotal assets: $15.9MNetIncomeLoss / Assets
Return on equity-243.6%FY2025Net income: -$17.2MShareholders equity: $7.1MNetIncomeLoss / StockholdersEquity
Liabilities / assets58.1%FY2025Total liabilities: $9.2MTotal assets: $15.9MLiabilities / Assets
Cash / assets0.6%FY2025Cash and equivalents: $88KTotal assets: $15.9MCashAndCashEquivalentsAtCarryingValue / Assets

Mapping completeness

12 of 12

12 of 12 canonical metrics were filled from this company's filings through the explicit tag map. Tags outside that map are recorded and counted, and are never used as a value.

Revenue by fiscal year

annual, as filed
  • 2017$5.9M
  • 2018$6.3M
  • 2019$7.2M
  • 2020$4.4M
  • 2021$22K
  • 2022$14K
  • 2023$442K
  • 2024$420K
  • 2025$819K

Net income by fiscal year

annual, as filed
  • 2017-$17.8M
  • 2018-$30.8M
  • 2019-$57M
  • 2020-$36M
  • 2021-$25.1M
  • 2022-$26.9M
  • 2023-$70.6M
  • 2024-$16.6M
  • 2025-$17.2M

Revenue by fiscal quarter

quarterly, as filed

Annual figures

10 fiscal years shown
Metric2025202420232022202120202019201820172016
Revenue$819K$420K$442K$14K$22K$4.4M$7.2M$6.3M$5.9M
Gross profit$756K$378K$412K-$147K-$1.5M-$1.1M-$1.7M$2.1M$1.7M
Operating income-$21.1M-$11.2M-$78.1M-$27M-$29.3M-$36.1M-$57.7M-$31.2M-$17.8M
Net income-$17.2M-$16.6M-$70.6M-$26.9M-$25.1M-$36M-$57M-$30.8M-$17.8M
Operating cash flow-$8.3M-$9.3M-$20.6M-$22.6M-$27.6M-$28.3M-$33.2M-$18.5M-$5.5M
Total assets$15.9M$27.8M$30.7M$16.8M$21M$33.4M$44.1M$74M$11.3M
Total liabilities$9.2M$16M$9.5M$7.6M$7.4M$12.3M$10.9M$7.3M$18.9M
Shareholders equity$7.1M$11.8M$21.2M$9.3M$13.7M$21.1M$33.2M$66.7M-$7.6M-$380K
Cash and equivalents$88K$2.9M$3.6M$15.9M$15M$23.9M$14.6M$64.3M$8.2M$3.9M
Shares outstanding1,738,9558,004,6337,026,6272,161,0007,0103,188,67913,770,34912,689,2517,888,170
EPS, basic-$15.90-$6.68-$129.88-$25.98-$248.22-$21.22-$4.33-$3.34-$2.35
EPS, diluted-$25.98-$248.22-$21.22-$4.33-$3.34-$2.35

Quarterly figures

12 fiscal quarters shown
Metric2026 Q12025 Q32025 Q22025 Q12024 Q32024 Q22024 Q12023 Q32023 Q22023 Q12022 Q32022 Q2
Revenue$432K$226K$212K$143K$96K$93K$82K$133K$96K$85K$0$5K
Gross profit$390K$208K$198K$132K$86K$77K$77K$127K$89K$75K$0-$61K
Operating income-$2.3M-$3M-$4.7M-$3.6M-$2.9M-$2.7M-$2.6M-$2.7M-$6.3M-$66.5M-$4.8M-$8.5M
Net income-$1.7M-$2.3M-$5.1M-$4M-$4.1M-$4.2M-$2.7M-$1.9M-$1.6M-$66.4M-$4.8M-$8.4M
Operating cash flow-$2.8M-$2.3M-$1.9M-$12.1M
Total assets$35.1M$25.5M$25.6M$24.8M$26.7M$26.3M$28M$32.9M$35.5M$48.5M$17.5M$14.4M
Total liabilities$25.9M$19M$19M$16.9M$13.9M$11.9M$9.5M$11M$11.8M$12.6M$5M$4.6M
Shareholders equity$9.6M$6.8M$6.8M$7.9M$12.8M$14.3M$18.5M$21.9M$23.8M$35.9M$12.5M$9.8M
Cash and equivalents$441K$1.1M$838K$450K$1.3M$16K$1.5M$5.6M$7.4M$12.2M$13.7M$11.1M
Shares outstanding2,692,4731,647,10518,861,5799,268,6323,452,652757,3407,573,4037,008,0025,367,6745,267,0921,423,00032,279,000
EPS, basic-$1.39-$1.70-$0.38-$0.36-$38.17-$5.57-$3.60-$4.36-$0.26
EPS, diluted-$4.36-$0.26

Latest figure against the peer median

all 722 companies with figures on record
An industry classification is not on record for this company, so the comparison group is every company whose figures we hold, across all sectors. The median is stated with the group it was computed over; it is a fact about that group and nothing more.
MetricLatest annual figurePeer medianDifferenceCompanies in groupSource tag
Revenue · FY2025$819K$422.2M 99.8%629RevenueFromContractWithCustomerExcludingAssessedTax
Gross profit · FY2025$756K$129.2M 99.4%349GrossProfit
Operating income · FY2025-$21.1M-$3.8M 457.1%591OperatingIncomeLoss
Net income · FY2025-$17.2M$2.4M 802.2%716NetIncomeLoss
Operating cash flow · FY2025-$8.3M$20.1M 141.2%715NetCashProvidedByUsedInOperatingActivities
Total assets · FY2025$15.9M$1.1B 98.6%720Assets
Total liabilities · FY2025$9.2M$458.2M 98.0%664Liabilities
Shareholders equity · FY2025$7.1M$301M 97.7%716StockholdersEquity
Cash and equivalents · FY2025$88K$82.6M 99.9%688CashAndCashEquivalentsAtCarryingValue
Shares outstanding · FY20251,738,95549,628,137 96.5%606CommonStockSharesOutstanding
EPS, basic · FY2025-$15.90$0.05 31,900.0%678EarningsPerShareBasic
EPS, diluted · FY2022-$25.98$0.03 104,020.0%678EarningsPerShareDiluted

Where the numbers come from

every figure traces to a filing
MetricFiscal periodPeriod endFiledFormAccessionXBRL tag
RevenueFY20252025-12-312026-03-3110-K0001437749-26-010549RevenueFromContractWithCustomerExcludingAssessedTax
Gross profitFY20252025-12-312026-03-3110-K0001437749-26-010549GrossProfit
Operating incomeFY20252025-12-312026-03-3110-K0001437749-26-010549OperatingIncomeLoss
Net incomeFY20252025-12-312026-03-3110-K0001437749-26-010549NetIncomeLoss
Operating cash flowFY20252025-12-312026-03-3110-K0001437749-26-010549NetCashProvidedByUsedInOperatingActivities
Total assetsFY20252025-12-312026-03-3110-K0001437749-26-010549Assets
Total liabilitiesFY20252025-12-312026-03-3110-K0001437749-26-010549Liabilities
Shareholders equityFY20252025-12-312026-03-3110-K0001437749-26-010549StockholdersEquity
Cash and equivalentsFY20252025-12-312026-03-3110-K0001437749-26-010549CashAndCashEquivalentsAtCarryingValue
Shares outstandingFY20252025-12-312026-03-3110-K0001437749-26-010549CommonStockSharesOutstanding
EPS, basicFY20252025-12-312026-03-3110-K0001437749-26-010549EarningsPerShareBasic
EPS, dilutedFY20222022-12-312023-03-2810-K0001564590-23-004567EarningsPerShareDiluted

Source: U.S. Securities and Exchange Commission, EDGAR company facts · as of 2026-03-31

Catheter Precision, Inc. financial figures — 10 fiscal years on record — Tapewire